Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 7/20 | 0.65 |
| ▸ | CA1 | P00915 | 7/20 | 0.65 |
| ▸ | CA2 | P00918 | 7/20 | 0.65 |
| ▸ | CA7 | P43166 | 7/20 | 0.65 |
| ▸ | CA9 | Q16790 | 7/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 7/20 | 0.65 |
| ▸ | EGFR | P00533 | 4/20 | 0.63 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.52 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.46 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | MIF | P14174 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30227090 | 1.00 | CA12 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL14344780 | 0.85 | EGFR (0.52) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3294852 | 0.85 | CA12 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL24991838 | 0.84 | CA12 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2218707 | 0.84 | CSNK2A1 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL15105925 | 0.84 | EGFR (0.48) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2616107 | 0.82 | CYP3A4 (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL20570435 | 0.82 | EGFR (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9600264 | 0.82 | EGFR (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8143660 | 0.82 | HPGD (0.56) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1675590-A | Photosensitive composition for interlayer dielectric and method of forming patterned interlayer dielectric | AZ ELECTRONIC MATERIALS JAPAN (JP) | 2005-09-28 | — | — | CN | claimed |
| US-20030096189-A1 | ONIUM SALTS AND POSITIVE RESIST MATERIALS USING THE SAME | YAGIHASHI FUJIO (JP) | 2003-05-22 | — | — | US | claimed |
| US-20220017942-A1 | COMPOSITIONS AND METHODS FOR DETERMINING THE PRESENCE OF ACTIVE LEUKOCYTE CELLS USING AN ELECTROCHEMICAL ASSAY | CLEU DIAGNOSTICS, LLC | 2022-01-20 | — | — | US | disclosed |
| US-20210371898-A1 | COMPOSITIONS AND METHODS FOR DETERMINING THE PRESENCE OF ACTIVE LEUKOCYTE CELLS USING AN ELECTROCHEMICAL ASSAY | CLEU DIAGNOSTICS, LLC | 2021-12-02 | — | — | US | disclosed |
| EP-3856710-A1 | COMPOSITIONS AND METHODS FOR DETERMINING THE PRESENCE OF ACTIVE LEUKOCYTE CELLS USING AN ELECTROCHEMICAL ASSAY | Parvizi Surgical Innovation, LLC (US) | 2021-08-04 | — | — | EP | disclosed |
| WO-2020069176-A1 | COMPOSITIONS AND METHODS FOR DETERMINING THE PRESENCE OF ACTIVE LEUKOCYTE CELLS USING AN ELECTROCHEMICAL ASSAY | PARVIZI SURGICAL INNOVATION, LLC (US) | 2020-04-02 | — | — | WO | disclosed |
| CN-105706000-A | Positive photosensitive resin composition, method for producing film using same, and electronic component | 中央硝子株式会社 | 2016-06-22 | — | — | CN | disclosed |
| EP-2584896-A2 | HERBICIDAL COMPOSITIONS | BASF SE (DE) | 2013-05-01 | — | — | EP | disclosed |
| US-20130102463-A1 | Herbicidal Compositions | BASF SE (DE) | 2013-04-25 | — | — | US | disclosed |
| WO-2011161105-A2 | HERBICIDAL COMPOSITIONS | BASF SE (DE) | 2011-12-29 | — | — | WO | disclosed |
| CN-1675590-A | Photosensitive composition for interlayer dielectric and method of forming patterned interlayer dielectric | AZ ELECTRONIC MATERIALS JAPAN (JP) | 2005-09-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220017942-A1 | COMPOSITIONS AND METHODS FOR DETERMINING THE PRESENCE OF ACTIVE LEUKOCYTE CELLS USING AN ELECTROCHEMICAL ASSAY | MPO, LPO, EPX | CA12 1192/4885CA1 1100/4885CA2 2308/4885 |
| US-20130102463-A1 | Herbicidal Compositions | PPOX, PAOX, DDT | CA12 3500/4885CA1 1296/4885CA2 1050/4885 |
| US-20210371898-A1 | COMPOSITIONS AND METHODS FOR DETERMINING THE PRESENCE OF ACTIVE LEUKOCYTE CELLS USING AN ELECTROCHEMICAL ASSAY | MPO, LPO, EPX | CA12 1192/4885CA1 1100/4885CA2 2308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.